08:53 AM EST, 11/07/2024 (MT Newswires) -- Haemonetics ( HAE ) reported fiscal Q2 adjusted earnings Thursday of $1.12 per diluted share, up from $0.99 a year earlier.

Analysts polled by Capital IQ expected $1.07.

Net revenue for the quarter ended Sept. 28 was $345.5 million, up from $318.2 million.

Analysts polled by Capital IQ expected $342.6 million.

The company said it continues to expect fiscal year 2025 adjusted EPS of $4.45 to $4.75. Analysts surveyed by Capital IQ are looking for $4.59.

Price: 81.50, Change: +3.34, Percent Change: +4.27